Xencor (XNCR) Change in Cash (2013 - 2026)
Xencor (XNCR) posted quarterly Change in Cash of -$40.0 million for Q1 2026, down 2969.92% year-over-year from $1.4 million in Q1 2025, and down 255.14% quarter-over-quarter from $25.8 million in Q4 2025.
Analysis
Xencor (XNCR) Change in Cash (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Change in Cash for 14 consecutive years, with -$40.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 2969.92% year-over-year to -$40.0 million; the TTM figure through Mar 2026 stood at -$25.6 million (down 399.64% YoY), while the FY2025 annual figure was $13.1 million, up 201.49% from the prior year.
- Change in Cash declined to -$40.0 million in Q1 2026 per XNCR's latest filing, from $25.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $25.8 million in Q4 2025 and bottomed at -$65.2 million in Q1 2022.
- Historically, Change in Cash has averaged -$7.6 million across 5 years, with a median of -$264000.0 in 2024.
- Annual changes were most pronounced in 2025 — Change in Cash soared 1906.44% — and 2026, when it slumped 2969.92%.
- Xencor's Change in Cash stood at $1.3 million in 2022, then declined by 17.78% to $1.1 million in 2023, then jumped by 1018.6% to $11.8 million in 2024, then soared by 117.65% to $25.8 million in 2025, then slumped by 255.14% to -$40.0 million in 2026.
- Business Quant data shows XNCR's Change in Cash at -$40.0 million in Q1 2026, $25.8 million in Q4 2025, and -$16.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | 30.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.49 Mn |
| Mar 31, 2026 | -40.00 Mn |
| Dec 31, 2025 | 25.78 Mn |
| Sep 30, 2025 | -16.15 Mn |
| Jun 30, 2025 | 4.77 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | 11.85 Mn |
| Sep 30, 2024 | -1.74 Mn |
| Jun 30, 2024 | -264,000.00 |
| Mar 31, 2024 | -22.75 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 18.40 Mn |
| Jun 30, 2023 | -37.68 Mn |
| Mar 31, 2023 | 18.45 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 3.24 Mn |
| Jun 30, 2022 | -28.86 Mn |
| Mar 31, 2022 | -65.21 Mn |
| Dec 31, 2021 | 102.28 Mn |
| Sep 30, 2021 | -74.64 Mn |